Efficacy of Ceftaroline against Methicillin-Susceptible Staphylococcus aureus Exhibiting the Cefazolin High-Inoculum Effect in a Rat Model of Endocarditis.

about

Efficacy of Ceftaroline against Methicillin-Susceptible Staphylococcus aureus Exhibiting the Cefazolin High-Inoculum Effect in a Rat Model of Endocarditis.

Item

http://www.wikidata.org/entity/Q38797012

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Efficacy of Ceftaroline agains ...... n a Rat Model of Endocarditis.

@en

type

Item

label

Efficacy of Ceftaroline agains ...... n a Rat Model of Endocarditis.

@en

prefLabel

Efficacy of Ceftaroline agains ...... n a Rat Model of Endocarditis.

@en

P1476

Efficacy of Ceftaroline agains ...... in a Rat Model of Endocarditis

@en

P2093

Barbara E Murray

http://www.w3.org/2001/XMLSchema#string

Cesar A Arias

http://www.w3.org/2001/XMLSchema#string

Kavindra V Singh

http://www.w3.org/2001/XMLSchema#string

Truc T Tran

http://www.w3.org/2001/XMLSchema#string

Vincent H Tam

http://www.w3.org/2001/XMLSchema#string

P2860

Real-time in vivo bioluminescent imaging for evaluating the efficacy of antibiotics in a rat Staphylococcus aureus endocarditis model

Importance of the collagen adhesin ace in pathogenesis and protection against Enterococcus faecalis experimental endocarditis.

Characterization of a chromosomal gene encoding type B beta-lactamase in phage group II isolates of Staphylococcus aureus.

Synergy of an investigational glycopeptide, LY333328, with once-daily gentamicin against vancomycin-resistant Enterococcus faecium in a multiple-dose, in vitro pharmacodynamic model

Telavancin versus standard therapy for treatment of complicated skin and skin structure infections caused by gram-positive bacteria: FAST 2 study

Pharmacodynamics of a new cephalosporin, PPI-0903 (TAK-599), active against methicillin-resistant Staphylococcus aureus in murine thigh and lung infection models: identification of an in vivo pharmacokinetic-pharmacodynamic target.

Comparison of in vivo and in vitro pharmacodynamics of a humanized regimen of 600 milligrams of Ceftaroline Fosamil every 12 hours against Staphylococcus aureus at initial inocula of 106 and 108 CFU per milliliter.

PBP2a mutations causing high-level Ceftaroline resistance in clinical methicillin-resistant Staphylococcus aureus isolates.

Telavancin versus vancomycin for hospital-acquired pneumonia due to gram-positive pathogens.

Pharmacokinetic-pharmacodynamic analysis for efficacy of ceftaroline fosamil in patients with acute bacterial skin and skin structure infections.

P31

scholarly article

P356

10.1128/AAC.00324-17

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Esteban C Nannini

P577

2017-06-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28483961

http://www.w3.org/2001/XMLSchema#string

P932

5487651

http://www.w3.org/2001/XMLSchema#string